NEW YORK (TheStreet) -- Intrexon
(XON) shares are up 2% to $25.18 on Wednesday after the company announced that it acquired Trans Ova Genetics for $60 million in cash, $30 million in Intrexon common stock and deferred payments of up to $20 million.
Trans Ova Genetics is the industry-leading provider of bovine reproductive technologies. Intrexon noted that the Food and Agricultural Organization of the United Nations (FAO) estimates that the demand for animal protein is set to double by 2040.
Must Read: Warren Buffett's 25 Favorite Stocks
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts